Articles - Page 4 of 69 - Drugs in Context

Dermatology: how to manage rosacea in skin of colour

Khalad Maliyar, Sonya J Abdulla

Article Type

Review

Published

31 May 2022

This article aims to raise awareness that rosacea is a global disease and to provide healthcare professionals with strategies to identify and manage rosacea amongst individuals with skin of colour.

Drugs for paediatric hyperinflammatory syndromes

Kam Lun Hon, Alexander KC Leung, Wing Hang Leung, Karen Ka Yan Leung, Kai Ning Cheong, Pamela PW Lee

Article Type

Review

Published

27 May 2022

This paper provides an updated narrative review on the pathophysiology, manifestations and management approaches for common hyperinflammatory syndromes.

Experience with sonidegib in patients with advanced basal cell carcinoma: case reports

Susana Puig, Carlos Serra-Guillén, Gemma Pérez-Pastor, Álvaro Martínez-Domenech, Ricardo Fernández-de-Misa Cabrera

Article Type

Case Series

Published

23 May 2022

Xeroderma pigmentosum: an updated review

Alexander KC Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong, Kam Lun Hon

Article Type

Review

Published

25 Apr 2022

This narrative review aims to familiarize physicians with the clinical features, diagnosis and management of xeroderma pigmentosum.

Tofacitinib and newer JAK inhibitors in inflammatory bowel disease – where we are and where we are going

Eleanor Liu, Nasar Aslam, Gaurav Nigam, Jimmy K Limdi

Article Type

Review

Published

11 Apr 2022

This narrative review summarizes the current literature regarding the mechanism of action of tofacitinib, data from registrational trials, emerging real-world evidence, and an overview of the most recent safety evidence. The authors explore evolving treatment paradigms and also present a brief overview of the next generation of JAK inhibitors in the pipeline.